ClinicalTrials.gg
CompletedNCT07834424Updated Oct 14, 2026

Direct Pulp Capping With Biodentine in Permanent Teeth With Reversible Pulpitis

An interventional study of Direct pulp capping with Biodentine in Reversible Pulpitis and Dental Pulp Exposure, sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. Completed at 1 site in Vietnam. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Nov 2025, registered Sep 2026).
Updated Oct 14, 2026Now CompletedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the clinical and radiographic outcomes of direct pulp capping using Biodentine (Septodont, Saint-Maur-des-Fossés, France), a calcium silicate-based cement, in mature permanent teeth diagnosed with reversible pulpitis following carious or mechanical pulp exposure. Biodentine was placed as a full-thickness (bulk) capping and interim restoration, with a definitive composite restoration completed at a later visit. Pulp vitality, postoperative pain, and radiographic healing are assessed over a 6-month follow-up period.

Read the detailed description

Mature permanent teeth clinically diagnosed with reversible pulpitis and presenting vital pulp exposure (carious or mechanical) were treated with direct pulp capping. After caries removal under rubber dam isolation, haemostasis of the exposed pulp was achieved with 2.5% sodium hypochlorite. Biodentine (Septodont, Saint-Maur-des-Fossés, France), a calcium silicate-based cement, was then placed as a full-thickness (bulk) direct pulp capping material, filling the cavity and serving as an interim restoration. At a subsequent visit (approximately 2 to 6 weeks later), the superficial layer of Biodentine was reduced and a definitive composite restoration was placed. Participants were followed clinically and radiographically at 1 week, 1 month, 3 months, and 6 months to assess pulp vitality, symptoms, and periapical status, including dentin bridge formation.

02

Conditions studied

  • Reversible Pulpitis
  • Dental Pulp Exposure

Browse trials for

Keywords

  • Direct pulp capping
  • Biodentine
  • Vital pulp therapy
  • Calcium silicate cement
03

In context

Dental Pulp Exposure

31 studies on the registry are indexed under Dental Pulp Exposure; 5 are open to participants now.

This study's enrollment of 12 is below the median of 53 across 29 interventional studies indexed under Dental Pulp Exposure.

Browse Dental Pulp Exposure studies →

Lead sponsor

University of Medicine and Pharmacy at Ho Chi Minh City is the lead sponsor of 127 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mature permanent teeth clinically diagnosed with reversible pulpitis
  • Vital pulp exposure (carious or mechanical) confirmed intra-operatively
  • Positive response to pulp sensibility testing (cold and/or electric pulp test) at baseline
  • Successful haemostasis of the exposed pulp achieved within 6 minutes
  • Patient consent to follow-up

Exclusion criteria

Exclusion Criteria:

  • Irreversible pulpitis or pulp necrosis
  • Spontaneous or lingering pain
  • Radiographic periapical pathology
  • Haemostasis not achieved within the time limit
  • Non-restorable teeth
  • Teeth with periodontal compromise
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Direct pulp capping with Biodentine

    All participants received direct pulp capping with Biodentine placed as a full-thickness (bulk) capping and interim restoration, followed by a definitive composite restoration at a subsequent visit.

    Procedure: Direct pulp capping with Biodentine

Interventions

  • ProcedureDirect pulp capping with Biodentine

    After caries removal under rubber dam isolation, haemostasis of the exposed vital pulp was achieved with 2.5% sodium hypochlorite. Biodentine (Septodont, Saint-Maur-des-Fossés, France), a calcium silicate-based cement, was mixed and placed directly over the pulp exposure as a full-thickness (bulk) capping and interim restoration. At a subsequent visit (approximately 2 to 6 weeks later), the superficial Biodentine layer was reduced and a definitive composite restoration was placed.

06

What researchers measure

Primary outcomes

  1. Overall treatment success

    Number of teeth with overall treatment success, defined as meeting both clinical and radiographic success criteria simultaneously. Clinical success: no spontaneous or lingering pain, negative percussion test, normal peri-radicular soft tissue (no swelling or sinus tract), positive response to pulp sensibility testing (transient cold response and electric pulp test within normal limits), and no abnormal tooth discoloration. Radiographic success: normal peri-radicular structures with continuous lamina dura and non-widened periodontal ligament space, no new periapical radiolucency, no internal or external root resorption, and stable pulp chamber and canal morphology. Reported as the number of teeth meeting the success criteria.

    Time frame: 3 months, and 6 months

Secondary outcomes

  1. Postoperative pain intensity

    Postoperative pain intensity measured using the Visual Analogue Scale (VAS), a 0 to 10 scale where 0 indicates no pain and 10 indicates the worst imaginable pain (higher scores indicate a worse outcome).

    Time frame: 24 hours, day 2-7, week 2-4, 3 months, and 6 months

  2. Pulp vitality (sensibility response)

    Number of teeth retaining pulp vitality, defined as a positive response to pulp sensibility testing (cold test and/or electric pulp test). Reported as the number of teeth with a positive sensibility response.

    Time frame: Baseline, 1 month, 3 months, and 6 months

07

Study locations

1 site
  • Faculty of Odonto-Stomatology, University of Medicine and Pharmacy at Ho Chi Minh City
    Ho Chi Minh City, 70000, Vietnam
08

References and documents

Individual participant data

Plan to share: No — No individual participant data sharing plan has been established at this time.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in Sep 2026, 10 months.

Of 13 interventional studies with no phase under Dental Pulp Exposure, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 15. This study's 10 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2026
First posted
Sep 22, 2026
StartActual
Nov 5, 2025
Primary completionActual
Sep 25, 2026
CompletionActual
Sep 30, 2026
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 14, 2026
Show all 2 updates
  1. Oct 14, 2026
    Active, not recruiting→Completed
    + 2 other changes: verification date and date precision
  2. Sep 25, 2026
    Minor edits only
    + 1 other change: responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07834424
Responsible party
Le Thi My Linh (Principal Investigator, University of Medicine and Pharmacy at Ho Chi Minh City) — Principal investigator
First posted
Sep 22, 2026
Start date
Nov 5, 2025
Primary completion
Sep 25, 2026
Completion
Sep 30, 2026
Last update
Oct 14, 2026

Study contacts

Bao Chau T Vu, DDS, PhD
study director · University of Medicine and Pharmacy at Ho Chi Minh City
Huynh Anh Bui, DDS, PhD
study director · University of Medicine and Pharmacy at Ho Chi Minh City

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion